|
Market Closed -
Hong Kong S.E.
04:08:29 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 8.755 HKD | +0.75% |
|
+1.51% | +3.86% |
| 08-11 | CSPC Pharma Starts Phase 1 Trial of CAR-T Drug for Relapsed, Refractory Lupus | MT |
| 08-10 | CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 1093 Stock
- Consensus CSPC Pharmaceutical Group Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
